dan 2163 and 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide

dan 2163 has been researched along with 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boerner, R; Dresel, S; Frodl, T; Gründer, G; Hahn, K; la Fougère, C; Meisenzahl, EM; Möller, HJ; Scheuerecker, J; Schmitt, G; Schwarz, M; Stauss, J	1

Trials

1 trial(s) available for dan 2163 and 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide

Article	Year
Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study. Pharmacopsychiatry, 2008, Volume: 41, Issue:5 Topics: Adult; Amisulpride; Antipsychotic Agents; Benzamides; Corpus Striatum; Dose-Response Relationship, Drug; Female; Humans; Iodine Radioisotopes; Male; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Schizophrenia; Severity of Illness Index; Statistics, Nonparametric; Sulpiride; Tomography, Emission-Computed, Single-Photon	2008

Article

Year

Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study.

Pharmacopsychiatry, 2008, Volume: 41, Issue:5

Topics: Adult; Amisulpride; Antipsychotic Agents; Benzamides; Corpus Striatum; Dose-Response Relationship, Drug; Female; Humans; Iodine Radioisotopes; Male; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Schizophrenia; Severity of Illness Index; Statistics, Nonparametric; Sulpiride; Tomography, Emission-Computed, Single-Photon

2008